The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo

Abstract Background Kidney fibrosis is a hallmark of chronic kidney disease (CKD) and compromises the viability of transplanted human bone marrow-derived mesenchymal stromal cells (BM-MSCs). Hence, BM-MSCs were genetically-engineered to express the anti-fibrotic and renoprotective hormone, human rel...

詳細記述

書誌詳細

主要な著者:	Yifang Li, Alex Hunter, Miqdad M. Wakeel, Guizhi Sun, Ricky W. K. Lau, Brad R. S. Broughton, Ivan E. Oyarce Pino, Zihao Deng, Tingfang Zhang, Padma Murthi, Mark P. Del Borgo, Robert E. Widdop, Jose M. Polo, Sharon D. Ricardo, Chrishan S. Samuel
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2024-10-01
シリーズ:	Stem Cell Research & Therapy
主題:	Chronic kidney disease Fibrosis BM-MSCs Relaxin Genetic engineering
オンライン･アクセス:	https://doi.org/10.1186/s13287-024-03992-x
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!